Last Price
0.117
Today's Change
+0.014 (13.72%)
Day's Change
0.109 - 0.157
Trading Volume
257,348,036
Market Cap
11 Million
Shares Outstanding
96 Million
Avg Volume
14,306,084
Avg Price (50 Days)
0.14
Avg Price (200 Days)
2.04
PE Ratio
-1.44
EPS
-0.08
Earnings Announcement
18-Nov-2024
Previous Close
0.10
Open
0.12
Day's Range
0.1086 - 0.1574
Year Range
0.095 - 7.83
Trading Volume
257,380,214
1 Day Change
12.79%
5 Day Change
15.50%
1 Month Change
-18.95%
3 Month Change
-60.17%
6 Month Change
-96.38%
Ytd Change
-97.54%
1 Year Change
-94.17%
3 Year Change
-98.84%
5 Year Change
-98.84%
10 Year Change
-98.84%
Max Change
-98.84%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.